• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Mettler-Toledo International Inc. Reports First Quarter 2026 Results

    5/7/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $MTD alert in real time by email

    Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2026. Provided below are the highlights:

    • Reported sales increased 7% compared with the prior year. In local currency, sales increased 3% compared with the prior year reflecting an increase of 1% excluding acquisitions.
    • Net earnings per diluted share as reported (EPS) were $8.33, compared with $7.81 in the prior-year period. Adjusted EPS was $8.91, an increase of 9% over the prior-year amount of $8.19. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules.

    First Quarter Results

    Patrick Kaltenbach, President and Chief Executive Officer, stated, "We are pleased with our first quarter results as we delivered good performance in an increasingly uncertain market environment. Solid execution of our margin initiatives supported very good Adjusted EPS growth."

    GAAP Results

    EPS in the quarter was $8.33, compared with the prior-year amount of $7.81.

    Compared with the prior year, total reported sales increased 7% to $947.1 million. By region, reported sales increased 3% in the Americas, 12% in Europe, and 8% in Asia/Rest of World. Earnings before taxes amounted to $209.7 million, compared with $201.9 million in the prior year.

    Non-GAAP Results

    Adjusted EPS was $8.91, an increase of 9% over the prior-year amount of $8.19.

    Compared with the prior year, total sales in local currency increased 3%. By region, local currency sales increased 2% in the Americas, 1% in Europe, and 5% in Asia/Rest of World. Excluding acquisitions, first quarter local currency sales increased 1%, including flat sales in the Americas and 3% growth in Asia/Rest of World. Adjusted Operating Profit amounted to $246.2 million, compared with the prior-year amount of $236.7 million.

    Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.

    Outlook

    Management cautions that market conditions are uncertain and could change quickly. Based on today's assessment, management anticipates local currency sales for the second quarter of 2026 will increase approximately 3%. Adjusted EPS is forecast to be $10.70 to $10.85, a growth rate of 6% to 8%.

    For the full year 2026, management anticipates local currency sales will increase approximately 4%. Adjusted EPS is forecast to be in the range of $46.30 to $46.95, representing growth of approximately 8% to 10%. This compares with previous local currency sales growth guidance of approximately 4% and Adjusted EPS guidance of $46.05 to $46.70.

    The Company does not provide GAAP financial measures on a forward-looking basis because we are unable to predict with reasonable certainty and without unreasonable effort the timing and amount of future restructuring and other non-recurring items.

    Conclusion

    Kaltenbach concluded, "Our investments in innovation continue to provide tangible benefits and also position us strongly to capitalize on our customers' investments in automation, digitalization, and onshoring in the future. While we recognize increased uncertainty in the macroeconomic environment, we remain confident in our agility and the strong execution of our growth and margin expansion programs to achieve solid Adjusted EPS growth this year."

    Other Matters

    The Company will host a conference call to discuss its quarterly results tomorrow morning (Friday, May 8) at 8:30 a.m. Eastern Time. To listen to a live webcast or replay of the call, visit the investor relations page on the Company's website at investor.mt.com. The presentation referenced on the conference call will be located on the website prior to the call.

    METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.

    Forward-Looking Statements Disclaimer

    You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties. You can identify forward-looking statements by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential," or "continue."

    We make forward-looking statements in this Quarterly Report about future events or our future financial performance, including sales and earnings growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position, pricing, capital expenditures, cash flow, share repurchases, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions, the impact of inflation, ongoing developments related to global trade disputes/tariffs, governmental policies, the geopolitical environment, the conflict in Ukraine and continuing instability in the Middle East on our business.

    Our forward-looking statements may not be accurate or complete, speak only as of the date of this Quarterly Report, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including ongoing developments related to global trade disputes/tariffs, governmental policies, the geopolitical environment, inflation, the conflict in Ukraine and continuing instability in the Middle East. See in particular "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2025 and other reports filed with the SEC from time to time.

    METTLER-TOLEDO INTERNATIONAL INC.
    CONSOLIDATED STATEMENTS OF OPERATIONS
    (amounts in thousands except share data)
    (unaudited)
     
    Three months ended Three months ended
    March 31, 2026 % of sales March 31, 2025 % of sales
     
    Net sales

    $947,127

    (a)

    100.0

    $883,744

    (a)

    100.0

    Cost of sales

    391,311

    41.3

    357,865

    40.5

    Gross profit

    555,816

    58.7

    525,879

    59.5

     

     

     

     

    Research and development

    51,275

    5.4

    46,346

    5.2

    Selling, general and administrative

    258,326

    27.3

    242,799

    27.5

    Amortization

    19,612

    2.1

    17,193

    2.0

    Interest expense

    17,007

    1.8

    16,653

    1.9

    Restructuring charges

    7,270

    0.8

    3,767

    0.4

    Other charges (income), net

    (7,329)

    (0.8)

    (2,821)

    (0.3)

    Earnings before taxes

    209,655

    22.1

    201,942

    22.8

     

     

     

     

    Provision for taxes

    40,201

    4.2

    38,355

    4.3

    Net earnings

    $169,454

    17.9

    $163,587

    18.5

     

     

    Basic earnings per common share:

     

     

    Net earnings

    $8.35

    $7.84

    Weighted average number of common shares

    20,286,133

    20,868,873

     

     

    Diluted earnings per common share:

     

     

    Net earnings

    $8.33

    $7.81

    Weighted average number of common and common equivalent shares

    20,338,274

    20,945,188

     
    Note:

    (a) Local currency sales increased 3% as compared to the same period in 2025.

     
    RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT
     
    Three months ended Three months ended
    March 31, 2026 % of sales March 31, 2025 % of sales
     
    Earnings before taxes

    $209,655

    $201,942

    Amortization

    19,612

    17,193

    Interest expense

    17,007

    16,653

    Restructuring charges

    7,270

    3,767

    Other charges (income), net

    (7,329)

    (2,821)

    Adjusted operating profit

    $246,215

    (b)

    26.0

    $236,734

    26.8

     
    Note:

    (b) Adjusted operating profit increased 4% as compared to the same period in 2025.

    METTLER-TOLEDO INTERNATIONAL INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (amounts in thousands)

    (unaudited)

     
     
    March 31, 2026 December 31, 2025
     
    Cash and cash equivalents

    $60,574

    $66,888

    Accounts receivable, net

    708,206

    778,243

    Inventories

    404,826

    387,228

    Other current assets and prepaid expenses

    158,305

    130,308

    Total current assets

    1,331,911

    1,362,667

     

     

    Property, plant and equipment, net

    830,329

    845,636

    Goodwill and other intangibles assets, net

    1,010,637

    1,018,135

    Other non-current assets

    496,038

    486,208

    Total assets

    $3,668,915

    $3,712,646

     

     

    Short-term borrowings and maturities of long-term debt

    $67,042

    $63,931

    Trade accounts payable

    228,719

    266,628

    Accrued and other current liabilities

    812,600

    867,557

    Total current liabilities

    1,108,361

    1,198,116

     

     

    Long-term debt

    2,161,596

    2,088,241

    Other non-current liabilities

    440,841

    449,925

    Total liabilities

    3,710,798

    3,736,282

     

     

    Shareholders' equity

    (41,883)

    (23,636)

    Total liabilities and shareholders' equity

    $3,668,915

    $3,712,646

    METTLER-TOLEDO INTERNATIONAL INC.
    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
    (amounts in thousands)
    (unaudited)
     
    Three months ended
    March 31,

    2026

    2025

     
    Cash flow from operating activities:
    Net earnings

    $169,454

    $163,587

    Adjustments to reconcile net earnings to net cash provided by operating activities:
    Depreciation

    13,160

    12,464

    Amortization

    19,612

    17,193

    Deferred tax provision (benefit)

    (1,994)

    (879)

    Share-based compensation

    5,469

    5,139

    Proceeds from government grant (a)

    6,240

    -

    Decrease in cash resulting from changes in operating assets and liabilities

    (72,147)

    (3,055)

    Net cash provided by operating activities

    139,794

    194,449

     
    Cash flows from investing activities:
    Purchase of property, plant and equipment

    (17,414)

    (17,255)

    Acquisitions

    (2,242)

    -

    Other investing activities

    (11,692)

    10,348

    Net cash used in investing activities

    (31,348)

    (6,907)

     
    Cash flows from financing activities:
    Proceeds from borrowings

    513,590

    512,496

    Repayments of borrowings

    (420,104)

    (479,326)

    Proceeds from exercise of stock options

    620

    2,198

    Repurchases of common stock

    (206,250)

    (218,749)

    Acquisition contingent consideration paid

    (2,190)

    -

    Other financing activities

    -

    (764)

    Net cash used in financing activities

    (114,334)

    (184,145)

     
    Effect of exchange rate changes on cash and cash equivalents

    (426)

    1,532

     
    Net increase in cash and cash equivalents

    (6,314)

    4,929

     
    Cash and cash equivalents:
    Beginning of period

    66,888

    59,362

    End of period

    $60,574

    $64,291

     
     

    RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW

     
    Three months ended
    March 31,

    2026

    2025

     
    Net cash provided by operating activities

    $139,794

    $194,449

    Payments in respect of restructuring activities

    3,436

    2,566

    Payments for acquisition transaction costs

    137

    -

    Proceeds from government grant (a)

    (6,240)

    -

    Purchase of property, plant and equipment, net

    (17,414)

    (17,255)

    Adjusted free cash flow

    $119,713

    $179,760

    (a)

    In December 2025, the Company entered into an agreement with the government of Xuhui, China to increase production automation and capacity and improve logistics. The Company will receive proceeds of approximately $31 million, of which approximately $18 million is expected to offset future purchases of property, plant and equipment and approximately $13 million is expected to offset future operating expenses. For the three months ended March 31, 2026, funding proceeds of $6.2 million that will offset future operating expenses is excluded from Adjusted free cash flow.

    METTLER-TOLEDO INTERNATIONAL INC.
    OTHER OPERATING STATISTICS
    SALES GROWTH BY DESTINATION
    (unaudited)
    Americas   Europe  

    Asia/RoW

    Total
    U.S. Dollar Sales Growth
    Three Months Ended March 31, 2026

    3%

    12%

    8%

    7%

    Local Currency Sales Growth
    Three Months Ended March 31, 2026

    2%

    1%

    5%

    3%

    Note:
    (a)   Net sales in local currency excluding acquisitions grew 1%, including flat sales in the Americas and 3% sales growth in Asia/Rest of World, for the three months ended March 31, 2026.
    RECONCILIATION OF DILUTED EPS AS REPORTED TO ADJUSTED DILUTED EPS 
    (unaudited)
         
      Three months ended
      March 31,
     

    2026

     

    2025

      % Growth
         
    EPS as reported, diluted  

    $8.33

     

    $7.81

     

    7%

         
    Purchased intangible amortization, net of tax  

            0.27

      (a)

            0.23

      (a)
    Restructuring charges, net of tax  

            0.29

      (b)

            0.15

      (b)
    Income tax expense  

            0.02

      (c)

                -  

     
         
    Adjusted EPS, diluted  

    $8.91

     

    $8.19

     

    9%

    Notes:
    (a)   Represents the EPS impact of purchased intangibles amortization of $7.1 million ($5.4 million after tax) and $6.3 million ($4.9 million after tax) for the three months ended March 31, 2026 and 2025, respectively.
    (b)   Represents the EPS impact of restructuring charges of $7.3 million ($5.9 million after tax) and $3.8 million ($3.1 million after tax) for the three months ended March 31, 2026 and 2025, respectively, which primarily include employee related costs.
    (c)   Represents the EPS impact of the difference between our quarterly and estimated annual tax rate before non-recurring discrete items during the three months ended March 31, 2026 due to the timing of excess tax benefits associated with stock option exercises.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260507744027/en/

    Adam Uhlman

    Head of Investor Relations

    METTLER TOLEDO

    Direct: 614-438-4794

    adam.uhlman@mt.com

    Get the next $MTD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MTD

    DatePrice TargetRatingAnalyst
    6/2/2026Peer Perform
    Wolfe Research
    3/20/2026$1450.00Hold → Buy
    Jefferies
    12/15/2025$1600.00Neutral → Buy
    BofA Securities
    12/9/2025$1475.00Neutral
    Goldman
    12/2/2025$1550.00Equal-Weight
    Morgan Stanley
    6/24/2025$1325.00Overweight
    Barclays
    5/20/2025$1350.00Neutral → Buy
    UBS
    5/5/2025$1110.00Underperform → Hold
    Jefferies
    More analyst ratings

    $MTD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Head of Asia & Pacific Wong Ann Ping Richard was granted 103 shares, increasing direct ownership by 19% to 645 units (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    5/14/26 10:48:04 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Head of PI, Retail, and GSC Wittorf Oliver was granted 87 shares, increasing direct ownership by 21% to 495 units (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    5/14/26 10:46:38 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chief Financial Officer Vadala Shawn was granted 291 shares, increasing direct ownership by 6% to 5,579 units (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    5/14/26 10:44:46 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mettler-Toledo International Inc. Reports First Quarter 2026 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2026. Provided below are the highlights: Reported sales increased 7% compared with the prior year. In local currency, sales increased 3% compared with the prior year reflecting an increase of 1% excluding acquisitions. Net earnings per diluted share as reported (EPS) were $8.33, compared with $7.81 in the prior-year period. Adjusted EPS was $8.91, an increase of 9% over the prior-year amount of $8.19. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chief Executive Off

    5/7/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. Announces Webcast of Presentation at the BofA Securities 2026 Healthcare Conference

    Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026, at 8:00 a.m. (PT). A live webcast of the presentation will be available on the Company's investor relations website at investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries inclu

    5/1/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. to Host First Quarter 2026 Earnings Conference Call

    Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its first quarter 2026 financial results after the market close on Thursday, May 7, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our

    4/9/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Diggelmann Roland D bought $323,360 worth of shares (315 units at $1,026.54), increasing direct ownership by 350% to 405 units (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    11/15/23 9:00:20 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research resumed coverage on Mettler-Toledo

    Wolfe Research resumed coverage of Mettler-Toledo with a rating of Peer Perform

    6/2/26 8:34:02 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo upgraded by Jefferies with a new price target

    Jefferies upgraded Mettler-Toledo from Hold to Buy and set a new price target of $1,450.00

    3/20/26 8:29:32 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo upgraded by BofA Securities with a new price target

    BofA Securities upgraded Mettler-Toledo from Neutral to Buy and set a new price target of $1,600.00

    12/15/25 9:08:50 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    SEC Filings

    View All

    SEC Form SD filed by Mettler-Toledo International Inc.

    SD - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

    5/29/26 7:02:22 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. filed SEC Form 8-K: Leadership Update

    8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

    5/13/26 8:56:40 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

    5/11/26 4:41:29 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Leadership Updates

    Live Leadership Updates

    View All

    Teleflex Announces Governance Updates

    Michael J. Tokich, Medical Technology Industry Veteran, Nominated as Independent Director; Andrew A. Krakauer Appointed Chairman of the Board Effective Following 2026 Annual Meeting Board to Establish Growth and Operating Committee Company to Commence Share Repurchases Ahead of Schedule Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced several Board and governance updates, including the nomination of Michael J. Tokich to the Board of Directors, its intent to establish a new Growth and Operating Committee of the Board and its plan to commence share repurchases under the Company's previously announced program ahead of schedule. The an

    4/9/26 6:30:00 AM ET
    $MTD
    $STE
    $TFX
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Industrial Specialties
    Health Care

    METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

    Mettler-Toledo International Inc. (NYSE:MTD) announced today that Michael J. Tokich has been appointed to its Board of Directors, effective February 5, 2026. Mr. Tokich served for over 17 years as Senior Vice President and Chief Financial Officer ("CFO") at STERIS plc (NYSE:STE), a leading global healthcare and life science provider of products and services, prior to recently transitioning to the role of Senior Financial Advisor at STERIS. Mr. Tokich joined STERIS in 2000 and held various senior financial roles prior to his appointment as CFO in 2008. Roland Diggelmann, Chair of the Board, stated, "Mike is a highly accomplished executive who brings nearly two decades of U.S. public comp

    1/20/26 4:30:00 PM ET
    $MTD
    $STE
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Industrial Specialties
    Health Care

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    $MTD
    Financials

    Live finance-specific insights

    View All

    Mettler-Toledo International Inc. Reports First Quarter 2026 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2026. Provided below are the highlights: Reported sales increased 7% compared with the prior year. In local currency, sales increased 3% compared with the prior year reflecting an increase of 1% excluding acquisitions. Net earnings per diluted share as reported (EPS) were $8.33, compared with $7.81 in the prior-year period. Adjusted EPS was $8.91, an increase of 9% over the prior-year amount of $8.19. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chief Executive Off

    5/7/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. to Host First Quarter 2026 Earnings Conference Call

    Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its first quarter 2026 financial results after the market close on Thursday, May 7, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our

    4/9/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. Reports Fourth Quarter 2025 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2025. Provided below are the highlights: Reported sales increased 8% compared with the prior year. In local currency, sales increased 5% compared with the prior year and included a 1% benefit from acquisitions. Net earnings per diluted share as reported (EPS) were $13.98, compared with $11.96 in the prior-year period. Adjusted EPS was $13.36, an increase of 8% over the prior-year amount of $12.41. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Fourth Quarter Results Patrick Kaltenbach, President and Chief Executive Office

    2/5/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/13/24 5:09:38 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/10/23 1:38:29 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/10/22 5:03:51 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials